Published in Pharma Investments, Ventures and Law Weekly, August 28th, 2005
"The aim of this study was to evaluate the clinical and therapeutic value of digital FI of PET using F-18-fluorodeoxy glucose and CT in patients who were suspected of having a local recurrence of rectal cancer," scientists writing in the journal Annals of Surgical Oncology reported.
"Forty-two patients (32 men and 10 women; mean age, 61.4 years, range, 40-79 years) with a suspicion of local recurrence after curative resection of rectal cancer were prospectively recruited and underwent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly